New patent for Bristol drug AUGTYRO

Fecha de publicación: 12/07/2024
Fuente: Biotechblog
Lugar: Patent Added
Annual Drug Patent Expirations for AUGTYRO Augtyro is a drug marketed by Bristol and is included in one NDA. It […]
Source
Source